India [SaneVax: The Supreme Court in India has issued scathing comments about the HPV vaccine ‘demonstration’ projects conducted in India with HPV vaccines, Gardasil and Cervarix, which were halted in 2010 under allegations of unethical conduct. Will HPV vaccines turn out to be nothing more than subterfuge in a syringe? The following press release from India explains […]
HPV Vaccine Fiasco in India: Government Issues Warning Letter
[SaneVax: It appears the most effective immunity vaccines offer is the immunity from prosecution. The Indian government investigation into the alleged ethics violations occurring during demonstration projects which were halted after allegations made by multiple medical professionals and local advocates have apparently come to a conclusion. The government response was simply a warning letter asking […]
False Claims by PATH to Institute HPV Vaccine Trials in India?
[SaneVax: According to the article below, PATH may have over-stated the cervical cancer burden in various parts of India in order to obtain permission to conduct clinical trials of HPV vaccines in India. Are they doing the same thing in other “PATH” countries? Once again, it appears we have a case of not providing the […]
Do cervical cancer data justify HPV vaccination in India? Epidemiological data sources and comprehensiveness
Published in the Journal of the Royal Society of Medicine; June 2012 105:229 Authors: I Mattheij,1 AM Pollock,2 P Brhlikova3 Summary The Indian government suspended research in April 2010 on the feasibility and safety of human papillomavirus (HPV) vaccine in two Indian states (Andhra Pradesh and Gujarat) amid public concerns about its safety. This paper describes cervical cancer […]
Path’s HPV Trials in India: Troubling Questions
[SaneVax: The questions Professor Allyson Pollock discusses with Newsclick regarding the Path sponsored Human Pappilomavirus Vaccine trials in Gujarat and Andhra Pradesh are the same questions every government in the world should be asking. She brings up many troubling issues raised by such trials, not just the more controversial one surrounding the lack of informed consent. […]
